Immunovant, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
IMVT Company Description
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).
IMVT Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view IMVT Smart Score
Score Breakdown
IMVT Company Description
Show More
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn). Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of IMVT by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by IMVT's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on IMVT's company Twitter account
WallStreetBets
Number of mentions of IMVT in WallStreetBets Daily Discussion
IMVT News
Recent insights relating to IMVT
CNBC Recommendations
Recent picks made for IMVT stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in IMVT
Corporate Flights
Flights by private jets registered to IMVT
Our Analysis